Skip to main
CTNM

CTNM Market Capitalization Overview

Market Cap: $416.07M as of Jan 2, 2026

$416.07M
$87.86M (26.77%)past month
As of Jan 2, 2026, CTNM has a market capitalization of $416.07M. Over the past 30 days, its market cap has increased by 28.27%, while in the last 12 months, it has decreased by -0.35%.

Market capitalization represents the total value of Contineum Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

CTNM Market Cap Formula = Stock Price * Shares Outstanding

The market cap of CTNM helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

CTNM Market Cap History

DateMarket CapChange
Dec 1, 2025$324.38M+3.19%
Nov 3, 2025$314.35M+1.81%
Oct 1, 2025$308.75M-1.43%
Sep 2, 2025$313.23M+103.14%
Aug 1, 2025$154.20M+54.81%
Jul 1, 2025$99.61M-13.09%
Jun 2, 2025$114.62M+11.59%
May 1, 2025$102.71M-38.54%
Apr 1, 2025$167.13M-1.62%
Mar 3, 2025$169.88M-29.67%
Feb 3, 2025$241.54M-35.29%
Jan 2, 2025$373.27M-4.36%

CTNM End of Year Market Cap History

DateMarket CapChange
2026$416.07M-0.35%
2025$417.54M+10.56%
2024$377.65M

FAQs About Contineum Therapeutics Inc (CTNM) Market Cap

As of Jan 2, 2026, the market capitalization of CTNM is $416.07M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Contineum Therapeutics Inc’s market capitalization has increased by 26.77%, changing from $328.22M to $416.07M as of Jan 2, 2026.

In the last 3 months, Contineum Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Contineum Therapeutics Inc’s market capitalization increased from $377.65M in January to $417.54M in December, reflecting a 10.56% change.

In the past five years, CTNM has had a compound annual growth rate (CAGR) of 5.15% in market capitalization. This means its market cap has grown at an average rate of 5.15% per year.

Contineum Therapeutics Inc (CTNM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.